Stamos Michael J MD is categorized under Internal Medicine Doctors in Orange, CA and active since 2007.
Stamos Michael J MD was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Michael Stamos at the company’s single location by writing to 333 City Boulevard West # 850, Orange, California CA 92868 or by phoning (714) 456-8511. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Stamos Michael J MD |
| Contact Person: | Michael Stamos |
| Address: | 333 City Boulevard West # 850, Orange, California 92868 |
| Phone Number: | (714) 456-8511 |
| Website Address: | uci.edu |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Stamos Michael J MD was started in 2007 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Michael Stamos for inquiries that concern Stamos Michael J MD by calling the company number (714) 456-8511, as your correspondence is most welcome. Additionally, the physical location of the single location of Stamos Michael J MD can be found at the coordinates 33.787475,-117.894084 as well as the street address 333 City Boulevard West # 850 in Orange, California 92868.
For its online presence, you may visit Stamos Michael J MD’s website at uci.edu and engage with its social media outlets through on Twitter and on Facebook.